SB 557 (2024)
Prohibit insurers from discriminating based on participation in federal drug pricing program
Summary:
Prohibits a health insurance issuer, pharmacy benefit manager, other third-party payer, or its agent from discriminating against an entity that participates in the federal 340B Drug Pricing Program. According to the federal Government Accountability Office, the 340B Program requires drug manufacturers to sell outpatient drugs at discounted prices at some hospitals for those drugs to be covered by Medicaid.
Status:
Public Hearing Date:
04/30/2024 11:00 am
Public Hearing Location:
LOB Room 302-304
Senate Voting Date:
03/07/2024
Want hearing dates, vote records or the full bill text? See more on the Statehouse website
https://gencourt.state.nh.us/bill_status/billinfo.aspx?id=2185&inflect=2
Browse related articles and bills:
